| Source: |
| Type: |
| For many drugs, the half-life is the time it takes for half of the drug’s active substance to be eliminated from the bloodstream. In medicine, knowing a drug’s half-life helps in designing treatment regimens that reduce adverse effects. |
| 5676- | BML, | Intestinal absorption of undegraded proteins in men: presence of bromelain in plasma after oral intake |
| - | in-vivo, | NA, | NA |
| 5654- | BNL, | Pharmacokinetics of natural borneol after oral administration in mice brain and its effect on excitation ratio |
| - | in-vivo, | Nor, | NA |
| 5669- | BNL, | Comparison of pharmacological activity and safety of different stereochemical configurations of borneol: L-borneol, D-borneol, and synthetic borneol |
| - | Review, | Nor, | NA | - | Review, | AD, | NA | - | Review, | Stroke, | NA |
| 5672- | Bor, | A comparative review of the pharmacokinetics of boric acid in rodents and humans |
| - | in-vivo, | Nor, | NA |
| 3516- | Bor, | Boron in wound healing: a comprehensive investigation of its diverse mechanisms |
| - | Review, | Wounds, | NA |
| 3502- | Bor, | Plasma boron concentrations in the general population: a cross-sectional analysis of cardio-metabolic and dietary correlates |
| - | Review, | NA, | NA |
| 3503- | Bor, | Chemical disposition of boron in animals and humans |
| - | Review, | NA, | NA |
| 3512- | Bor, | Activation of the EIF2α/ATF4 and ATF6 Pathways in DU-145 Cells by Boric Acid at the Concentration Reported in Men at the US Mean Boron Intake |
| - | in-vitro, | Pca, | DU145 |
| 4624- | Bor, | VitD3, | Boron as a Medicinal Ingredient in Oral Natural Health Products |
| - | Review, | Pca, | NA |
| 2767- | Bos, | The potential role of boswellic acids in cancer prevention and treatment |
| - | Review, | Var, | NA |
| 2772- | Bos, | Mechanistic role of boswellic acids in Alzheimer’s disease: Emphasis on anti-inflammatory properties |
| - | Review, | AD, | NA |
| 5825- | CAP, | Bioavailability of capsaicin and its implications for drug delivery |
| - | Review, | Var, | NA | - | Review, | Arthritis, | NA | - | Review, | Obesity, | NA |
| 5858- | CAP, | Capsaicin as a Microbiome Modulator: Metabolic Interactions and Implications for Host Health |
| - | Review, | Nor, | NA | - | Review, | AD, | NA |
| 5855- | CAP, | Unravelling the Mystery of Capsaicin: A Tool to Understand and Treat Pain |
| - | in-vivo, | Nor, | NA |
| 5854- | CAP, | Pharmacological activity of capsaicin: Mechanisms and controversies (Review) |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 2015- | CAP, | CUR, | urea, | Anti-cancer Activity of Sustained Release Capsaicin Formulations |
| - | Review, | Var, | NA |
| 5879- | CAR, | Pharmacokinetic analysis of thymol, carvacrol and diallyl disulfide after intramammary and topical applications in healthy organic dairy cattle |
| - | in-vivo, | Nor, | NA |
| 5928- | Catechins, | Bioavailability of Tea Catechins and Its Improvement |
| - | Review, | Nor, | NA |
| 5811- | CBC, | The Potential of Cannabichromene (CBC) as a Therapeutic Agent |
| - | Review, | Var, | NA |
| 5968- | CET, | Cetuximab as a Key Partner in Personalized Targeted Therapy for Metastatic Colorectal Cancer |
| - | in-vitro, | CRC, | NA |
| 6009- | CGA, | Chlorogenic Acid: An In-Depth Review of Its Effectiveness in Cancer Treatment |
| - | Review, | Var, | NA |
| 6024- | CGA, | Phase I study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up |
| - | Trial, | GBM, | NA |
| 6029- | CGA, | Pharmacokinetics of chlorogenic acids absorbed in human plasma and their metabolites following oral ingestion of coffee drink |
| - | Trial, | Nor, | NA |
| 6026- | CGA, | Chlorogenic Acid: The Conceivable Chemosensitizer Leading to Cancer Growth Suppression |
| - | Review, | Var, | NA |
| 6001- | Chit, | Recent advances in engineering chitosan-based nanoplatforms in biotherapeutic multi-delivery for multi-targeted disease treatments: Promises and outlooks |
| - | Review, | Var, | HepG2 | - | Review, | AD, | NA |
| 5982- | Chit, | Chitosan Nanoparticles-Based Cancer Drug Delivery: Application and Challenges |
| - | Review, | Var, | NA |
| 5991- | Chit, | Chitosan-Based Nanoencapsulated Essential Oils: Potential Leads against Breast Cancer Cells in Preclinical Studies |
| - | Review, | BC, | NA |
| 5999- | Chit, | How chitosan can help against breast cancer |
| - | Review, | BC, | NA |
| 5994- | Chit, | Anticancer Activity of Chitosan, Chitosan Derivatives, and Their Mechanism of Action |
| - | Review, | Var, | NA |
| 5990- | Chit, | Chitosan Nanoparticles for Targeted Cancer Therapy: A Review of Stimuli-Responsive, Passive, and Active Targeting Strategies |
| - | Review, | Var, | NA |
| 6093- | CHOC, | The relevance of theobromine for the beneficial effects of cocoa consumption |
| - | Review, | Nor, | NA | - | NA, | asthmatic, | NA |
| 2781- | CHr, | PBG, | Chrysin a promising anticancer agent: recent perspectives |
| - | Review, | Var, | NA |
| 3574- | CUR, | The effect of curcumin (turmeric) on Alzheimer's disease: An overview |
| - | Review, | AD, | NA |
| 4826- | CUR, | The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management |
| - | Review, | Var, | NA |
| 2809- | CUR, | Comparative absorption of curcumin formulations |
| - | in-vivo, | Nor, | NA |
| 1882- | DCA, | Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer |
| - | Analysis, | NA, | NA |
| 4913- | DSF, | Anticancer effects of disulfiram: a systematic review of in vitro, animal, and human studies |
| - | Review, | Var, | NA |
| 4916- | DSF, | Cu, | The immunomodulatory function and antitumor effect of disulfiram: paving the way for novel cancer therapeutics |
| - | Review, | Var, | NA |
| 1608- | EA, | Ellagic Acid from Hull Blackberries: Extraction, Purification, and Potential Anticancer Activity |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Liver, | HepG2 | - | in-vitro, | BC, | MCF-7 | - | in-vitro, | Lung, | A549 | - | in-vitro, | Nor, | HUVECs |
| 1614- | EA, | Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice |
| - | Human, | Nor, | NA |
| 3201- | EGCG, | Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential |
| - | Review, | NA, | NA |
| 1516- | EGCG, | Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential |
| - | Review, | NA, | NA |
| 2561- | EGCG, | ASA, | Anti-platelet effects of epigallocatechin-3-gallate in addition to the concomitant aspirin, clopidogrel or ticagrelor treatment |
| - | ex-vivo, | Nor, | NA |
| 3714- | FA, | Recent Advances in the Neuroprotective Properties of Ferulic Acid in Alzheimer's Disease: A Narrative Review |
| - | Review, | AD, | NA |
| 2824- | FIS, | Fisetin in Cancer: Attributes, Developmental Aspects, and Nanotherapeutics |
| - | Review, | Var, | NA |
| 2825- | FIS, | Exploring the molecular targets of dietary flavonoid fisetin in cancer |
| - | Review, | Var, | NA |
| 2827- | FIS, | The Potential Role of Fisetin, a Flavonoid in Cancer Prevention and Treatment |
| - | Review, | Var, | NA |
| 2516- | H2, | Hydrogen Gas in Cancer Treatment |
| - | Review, | Var, | NA |
| 2864- | HNK, | Honokiol: A Review of Its Anticancer Potential and Mechanisms |
| - | Review, | Var, | NA |
| 2885- | HNK, | Honokiol: a novel natural agent for cancer prevention and therapy |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1109 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid